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Purpose of the study
HAART has greatly modified the course of HIV-1 infec-
tion; however, its impact seems to be less favourable on
lymphoproliferative disorders associated with Epstein-
Barr virus (EBV) than on other AIDS-defining illnesses.
The aim of this study was to estimate the relationship
between EBV levels and other viro-immunological para-
meters in HIV-1 infected subjects in the HAART era.
Patients and methods
164 HIV-1 infected patients (pts) who attended the
Infectious Diseases Unit of Rovigo Hospital, from July
2007 to December 2009 were included in this study.
28% of patients had HBV and/or HCV coinfections.
HIV-1 RNA in plasma was quantified by COBAS Taq-
man HIV-1 test. HIV-1 DNA and EBV-DNA in periph-
eral blood mononuclear cells (PBMC) were determined
by real-time PCR. Lipopolysaccharide (LPS), a marker of
microbial translocation, was determined in plasma sam-
ples using a chromogenic assay (Limolus Amebocyte
Lysate). B-cell activation was analyzed by flow cytometry
using monoclonal antibodies CD19PerCP, CD86APC,
and CD69PE.
Results
The median (IQR) EBV-DNA load was 41(1-151)
copies/105 PBMC. 48% of pts had CD4 >500 cells/µl
and 27% had undetectable HIV viral load. The EBV-
DNA level was significantly higher in pts with CD4
below 500 cells/µl than in those with CD4 >500cells/µl
[72(14-324) vs 18 (1-80) copies/105; p<0.0001] and in
pts with detectable HIV-1 RNA than in those with
undetectable viremia [49(7-315) vs 17(1-55) copies/
105; p=0.001]. Levels of EBV-DNA were higher in the
group of pts with CD4 cell counts >500 cells/µl and
high HIV-1 viremia (>1000 copies/ml) than in pts with
low viremia, regardless of the immunological status [48
(5-153) vs 18(1-60); p=0.015). EBV-DNA was also sig-
nificantly higher in pts with coinfections than in pts
with no coinfections [85(10-527) vs 33(1-114); p=
0.003]. Furthermore, pts with high EBV loads (up to
75th percentile) had higher levels of HIV-1 DNA [40
(1-132) vs 10(1-76) HIV-DNA copies/105; p= 0.050)
and higher levels of LPS [130(88-244) vs 98(81-134)
pg/ml; p=0.024) than pts with low EBV loads. B-cell
activation in pts with high EBV loads was confirmed
by immunophenotyping; two of these pts developed a
B-cell lymphoma.
Conclusions
These findings suggest that HIV-1viremia, other coinfec-
tions, and immune activation play an important role in
the B-cell stimulation and expansion of EBV-infected
cells. Persistent HIV-1 viremia, despite immunereconsti-
tution, may represent a risk factor for the onset of EBV-
related cancers.
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